Liver transplantation: current status and novel approaches to liver replacement.
暂无分享,去创建一个
[1] T. Wright,et al. Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation , 1999, Hepatology.
[2] M. Mercado,et al. [Surgery in portal hypertension. Which patient and which operation?]. , 1993, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.
[3] R. Merion,et al. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants Broelsch CE, Emond JC, Whitington PF, Thistlethwaite JR, Baker AL, Lichtor JL. Ann Surg 1990;212:368–375 , 1991 .
[4] National Institutes of Health Consensus Development Conference Statement: Liver2 Transplantation‐June 20–23, 1983 , 1984, Hepatology.
[5] J. Platt,et al. The future promises of xenotransplantation. , 1998, Annals of the New York Academy of Sciences.
[6] B. Portmann,et al. A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation , 1998, Hepatology.
[7] R. Rubin,et al. Infection in organ-transplant recipients. , 1998, The New England journal of medicine.
[8] E. Keeffe. Liver transplantation at the millennium. Past, present, and future. , 2000, Clinics in liver disease.
[9] R. Fisher,et al. Single‐center analysis of the first 40 adult‐to‐adult living donor liver transplants using the right lobe , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[10] K. Detre,et al. Liver transplantation in the United States from 1987-1998: updated results from the Pitt-UNOS Liver Transplant Registry. , 1998, Clinical transplants.
[11] S. Fan,et al. Adult-to-adult living donor liver transplantation using extended right lobe grafts. , 1997, Annals of surgery.
[12] G. Klintmalm,et al. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. , 1993, Transplantation proceedings.
[13] D. Dunn,et al. CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORS , 1978, The Lancet.
[14] M. Bronner,et al. Hyperbilirubinemia and cholestatic liver injury in hepatitis C-infected liver transplant recipients. , 2000 .
[15] R. Busuttil,et al. Predictors of Survival After In Vivo Split Liver Transplantation: Analysis of 110 Consecutive Patients , 2000, Annals of surgery.
[16] D. Grant,et al. Biliary reconstruction without T tubes or stents in liver transplantation: report of 502 consecutive cases. , 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[17] Randall G. Lee,et al. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. , 1999, Gastroenterology.
[18] Zu-hua Gao,et al. From the Selectedworks of Vivian C. Mcalister Sirolimus-tacrolimus Combination Immunosuppression , 2022 .
[19] G. Klintmalm,et al. Transplantation of the Liver , 1996 .
[20] J. Emond,et al. Reduced‐size orthotopic liver transplantation: Use in the management of children with chronic liver disease , 1989, Hepatology.
[21] J. Emond,et al. Evolution and future perspectives for reduced-size hepatic transplantation. , 1990, Surgery, gynecology & obstetrics.
[22] H. Conjeevaram,et al. Modern immunosuppression. , 2000, Clinics in liver disease.
[23] R. Wiesner,et al. A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group. , 1998, Transplantation.
[24] George Y. Wu,et al. Chronic Viral Hepatitis: Diagnosis And Therapeutics , 2002 .
[25] V. Mazzaferro,et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.
[26] G. McCaughan. Selection of patients for liver transplantation , 1993, Journal of gastroenterology and hepatology.
[27] H. Bazin,et al. MONOCLONAL ANTIBODIES IN PROPHYLACTIC IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION A RANDOMIZED CONTROLLED TRIAL COMPARING OKT3 AND ANTI‐IL-2 RECEPTOR MONOCLONAL ANTIBODY LO‐TACT-1 , 1993, Transplantation.
[28] D. Dunn,et al. CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERS , 1979, The Lancet.
[29] A. Marcos. Right lobe living donor liver transplantation: A review , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[30] R. Wiesner,et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. , 1997, Gastroenterology.
[31] J. Emond,et al. Application of Reduced‐size Liver Transplants as Split Grafts, Auxiliary Orthotopic Grafts, and Living Related Segmental Transplants , 1990, Annals of surgery.
[32] R. Wiesner,et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. , 1998, Transplantation.
[33] Linda Sher,et al. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. , 1994, The New England journal of medicine.
[34] C. Meyer,et al. Liver transplantation for cholangiocarcinoma: results in 207 patients. , 2000, Transplantation.
[35] C. G. Child,et al. The liver and portal hypertension , 1964 .
[36] B. Nordlinger,et al. Intrasplenic hepatocellular transplantation corrects hepatic encephalopathy in portacaval‐shunted rats , 1992, Hepatology.
[37] J. de Ville de Goyet. Split liver transplantation in Europe--1988 to 1993. , 1995, Transplantation.
[38] J. Platt. Approaching Clinical Application of Xenotransplantation , 1997, The American journal of the medical sciences.
[39] G. Gores,et al. Prolonged disease‐free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[40] H. Vanderpool. Critical ethical issues in clinical trials with xenotransplants , 1998, The Lancet.
[41] E. Keeffe,et al. Prednisone withdrawal advocates: Beware of recurrent autoimmune hepatitis , 1999, Hepatology.
[42] W. Bechstein,et al. COMPARISON OF QUADRUPLE IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION WITH ATG OR IL‐2 RECEPTOR ANTIBODY , 1993, Transplantation.
[43] Y. Yamaoka,et al. Living Related Liver Transplantation for Children Younger than One Year Old , 1996, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.
[44] M. Kusano,et al. Hepatocyte Transplantation in Man , 1992, Transplantation proceedings.
[45] S. Raia,et al. LIVER TRANSPLANTATION FROM LIVE DONORS , 1989, The Lancet.
[46] J. Emond,et al. Split‐Liver Transplantation: A Review , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[47] T. Russell,et al. The impact of liver reductions in pediatric liver transplantation. , 1991, Archives of surgery.
[48] J. Goyet. Split liver transplantation in Europe--1988 to 1993. , 1995 .
[49] G. Klintmalm,et al. Liver transplantation with use of cyclosporin a and prednisone. , 1981, The New England journal of medicine.
[50] M. Schwartz,et al. Safe use of hepatic allografts from donors older than 70 years. , 1996, Transplantation.
[51] J. Chowdhury. Prospects of Liver Cell Transplantation and Liver-directed Gene Therapy , 1999, Seminars in liver disease.
[52] P. Kandela. South Africa: medical care of detainees. , 1985, Lancet.
[53] R. Carithers. Liver transplantation , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[54] K. Detre,et al. Influence of donor age on graft survival after liver transplantation--United Network for Organ Sharing Registry. , 1995, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[55] R. Wiesner,et al. Resource Utilization in Liver Transplantation: Effects of Patient Characteristics and Clinical Practice , 2000 .
[56] G. Alexander,et al. Liver transplantation in European patients with the hepatitis B surface antigen. , 1993, The New England journal of medicine.
[57] V. Arroyo,et al. Compensated cirrhosis: Natural history and prognostic factors , 1987, Hepatology.
[58] I. García,et al. Use of octogenarian livers safely expands the donor pool. , 1999 .
[59] T. Starzl,et al. HOMOTRANSPLANTATION OF THE LIVER IN HUMANS. , 1963, Surgery, gynecology & obstetrics.
[60] B. Koneru,et al. Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. , 1988, Transplantation proceedings.
[61] L. Ferrell,et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. , 1992, Gastroenterology.
[62] A. Bhalla,et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. , 1997, Gastroenterology.
[63] R. Reding. Steroid withdrawal in liver transplantation: benefits, risks, and unanswered questions. , 2000, Transplantation.
[64] J. Platt,et al. The Future Promises of Xenotransplantation a,b , 1998 .
[65] R. Pugh,et al. Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.
[66] T. Wright,et al. Hepatitis C infection in transplantation. , 1997, Clinics in liver disease.
[67] J. Najarian,et al. Liver Allograft Rejection : An Analysis of the Use of Biopsy in Determining Outcome of Rejection , 1987, The American journal of surgical pathology.
[68] W. Savage,et al. GYNAECOLOGISTS' ATTITUDES TO ABORTION , 1989, The Lancet.
[69] M. Sayegh,et al. Immunosuppressive strategies in transplantation , 1999, The Lancet.
[70] T. Starzl,et al. FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION , 1989, The Lancet.
[71] T. Starzl,et al. Baboon-to-human liver transplantation , 1993, The Lancet.
[72] E. Keeffe. Summary of guidelines on organ allocation and patient listing for liver transplantation. , 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[73] A. Gown,et al. Persistent hepatitis C virus infection after liver transplantation: Clinical and virological features , 1995, Hepatology.
[74] G. Everson,et al. Evaluation of 100 patients for living donor liver transplantation , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[75] Nina Singh,et al. Quality of life, functional status, and depression in male liver transplant recipients with recurrent viral hepatitis C. , 1999, Transplantation.
[76] C. Lo,et al. Applicability of living donor liver transplantation to high-urgency patients. , 1998, Transplantation.
[77] D. V. van Thiel,et al. Evolution of Liver Transplantation , 2007, Hepatology.
[78] R Williams,et al. Early indicators of prognosis in fulminant hepatic failure. , 1989, Gastroenterology.
[79] E. Keeffe,et al. Resection versus transplantation for hepatocellular carcinoma , 1999, Journal of Gastroenterology and Hepatology.
[80] S. Kawasaki,et al. Successful living-related partial liver transplantation to an adult patient , 1994, The Lancet.
[81] Donor age and outcome of liver transplantation , 1996 .
[82] A. Daar,et al. Ethics of Xenotransplantation: Animal Issues, Consent, and Likely Transformation of Transplant Ethics , 1997, World Journal of Surgery.
[83] R. Reding. STEROID WITHDRAWAL IN LIVER TRANSPLANTATION , 2000 .
[84] R. Rubin,et al. Evolving trends in liver transplantation: an outcome and charge analysis. , 1998, Transplantation.
[85] E. Keeffe,et al. Primary liver transplantation without transfusion of red blood cells. , 1996, Surgery.
[86] G. Alexander,et al. Sirolimus: a potent new immunosuppressant for liver transplantation. , 1999, Transplantation.
[87] R. Lee. Recurrence of alcoholic liver disease after liver transplantation. , 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[88] P. Angus,et al. Combination low‐dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[89] T. Starzl. History of liver and other splanchnic organ transplantation , 1996 .
[90] C. Goodman. United Network for Organ Sharing , 1988 .
[91] E. Keeffe,et al. Liver transplantation for alcoholic liver disease: selection and outcome. , 1997, Clinics in liver disease.
[92] G. Remuzzi,et al. Strategies for making more organs available for transplantation. , 2000, The New England journal of medicine.
[93] N. Terrault. HEPATITIS B VIRUS AND LIVER TRANSPLANTATION , 1999 .
[94] I. Olkin,et al. Health-related quality of life after liver transplantation: a meta-analysis. , 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[95] M. Chevallier,et al. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation , 1997, Hepatology.
[96] R. Calne,et al. PROLONGED SURVIVAL OF PIG ORTHOTOPIC HEART GRAFTS TREATED WITH CYCLOSPORIN A , 1978, The Lancet.
[97] M. Rela,et al. Split liver transplantation: King's College Hospital experience. , 1998, Annals of surgery.
[98] S. Strom,et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. , 1998, The New England journal of medicine.
[99] J. Neuberger. Recurrence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis. , 1995, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[100] S. Gupta,et al. Hepatocyte transplantation: emerging insights into mechanisms of liver repopulation and their relevance to potential therapies. , 1999, Journal of hepatology.
[101] S. Thung,et al. Retransplantation for recurrent hepatitis C. , 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[102] H. Rosen. Disease recurrence following liver transplantation. , 2000, Clinics in liver disease.
[103] K. Batts,et al. Recurrence of primary sclerosing cholangitis following liver transplantation , 1999, Hepatology.